Saxenda (Novo Nordisk)
Welcome to the PulseAid listing for the Saxenda drug offered from Novo Nordisk. This GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novo Nordisk |
| NON-PROPRIETARY NAME: | liraglutide |
| SUBSTANCE NAME: | LIRAGLUTIDE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | GLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (GLP-1) Agonists [MoA] |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-12-31 |
| END MARKETING DATE: | 0000-00-00 |
Saxenda HUMAN PRESCRIPTION DRUG Details:
| Item Description | Saxenda from Novo Nordisk |
| LABELER NAME: | Novo Nordisk |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 6(mg/mL) |
| START MARKETING DATE: | 2014-12-31 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0169-2800_aae420f9-d706-4f3a-bd39-2913a572c2f1 |
| PRODUCT NDC: | 0169-2800 |
| APPLICATION NUMBER: | NDA206321 |
Other LIRAGLUTIDE Pharmaceutical Manufacturers / Labelers:
